Key facts
- Active LCDs
- 174
- Contracts
- 30
- 01111, 01112, 01182, 01211, 01212, 01311, 01312, 01911, 02101, 02102, 02201, 02202, 02301, 02302, 02401, 02402, 03101, 03102, 03201, 03202, 03301, 03302, 03401, 03402, 03501, 03502, 03601, 03602, 16013, 19003
- States and territories
- 34
- AK AS AZ CA CNMI CT DC DE GU HI IA ID KS MA MD ME MO MT ND NE NF NH NJ NV NY OR PA RI SD SF UT VT WA WY
- Contractor site
- med.noridianmedicare.com/web/jdd
Jurisdictions
Contract numbers identify the jurisdiction on remittances and in the Medicare Coverage Database; A and B MAC contracts cover both institutional and professional claims, while DME and HHH contracts are national or regional specialty jurisdictions.
| Contract | Type | States |
|---|---|---|
| 01111 | A and B MAC | CA |
| 01112 | A and B MAC | NF |
| 01182 | A and B MAC | SF |
| 01211 | A and B MAC | AS CNMI GU HI |
| 01212 | A and B MAC | AS CNMI GU HI |
| 01311 | A and B MAC | NV |
| 01312 | A and B MAC | NV |
| 01911 | A and B MAC | AS CA CNMI GU HI NV |
| 02101 | A and B MAC | AK |
| 02102 | A and B MAC | AK |
| 02201 | A and B MAC | ID |
| 02202 | A and B MAC | ID |
| 02301 | A and B MAC | OR |
| 02302 | A and B MAC | OR |
| 02401 | A and B MAC | WA |
| 02402 | A and B MAC | WA |
| 03101 | A and B MAC | AZ |
| 03102 | A and B MAC | AZ |
| 03201 | A and B MAC | MT |
| 03202 | A and B MAC | MT |
| 03301 | A and B MAC | ND |
| 03302 | A and B MAC | ND |
| 03401 | A and B MAC | SD |
| 03402 | A and B MAC | SD |
| 03501 | A and B MAC | UT |
| 03502 | A and B MAC | UT |
| 03601 | A and B MAC | WY |
| 03602 | A and B MAC | WY |
| 16013 | DME MAC | CT DC DE MA MD ME NH NJ NY PA RI VT |
| 19003 | DME MAC | AK AS AZ CA CNMI GU HI IA ID KS MO MT ND NE NV OR SD UT WA WY |
Most recently effective LCDs
Revision effective dates signal where this contractor has tightened or loosened criteria; the ten newest are listed first, with the full list below.
| LCD | Title | Effective |
|---|---|---|
| L40265 | Peripheral Nerve Injections and Procedures for Chronic Pain | 2026-11-01 |
| L40242 | MolDX: Genetic Testing for Hereditary Thrombophilia | 2026-10-12 |
| L40222 | MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer | 2026-10-12 |
| L40324 | Allergy Diagnostic Testing | 2026-09-27 |
| L40060 | MolDX: Molecular Testing for Solid Organ Allograft Rejection | 2026-08-30 |
| L40062 | MolDX: Molecular Testing for Solid Organ Allograft Rejection | 2026-08-30 |
| L40255 | Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices | 2026-08-13 |
| L40197 | MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis | 2026-08-10 |
| L33794 | External Infusion Pumps | 2026-07-01 |
| L33610 | Intravenous Immune Globulin | 2026-07-01 |
All active LCDs (174)
- L40050 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)
- L40324 Allergy Diagnostic Testing
- L34313 Allergy Testing
- L39396 Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin
- L39116 Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
- L33686 Ankle-Foot/Knee-Ankle-Foot Orthosis
- L39881 Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT )/Coronary Plaque Analysis (AI-CPA)
- L33690 Automatic External Defibrillators
- L35526 B-type Natriuretic Peptide (BNP) Testing
- L37054 BDX-XL2
- L34233 Benign Skin Lesion Removal (Excludes Actinic Keratosis, and Mohs)
- L34194 Blepharoplasty, Eyelid Surgery, and Brow Lift
- L35170 Botulinum Toxin Injections
- L35172 Botulinum Toxin Injections
- L36267 Bowel Management Devices
- L33733 Canes and Crutches
- L34324 Cardiovascular Stress Testing, Including Exercise and/or Pharmacological Stress and Stress Echocardiography
- L34203 Cataract Surgery in Adults
- L39758 Cervical Fusion
- L33823 Cervical Traction Devices
- L37547 Chest X-Ray Policy
- L33735 Cold Therapy
- L38824 Colon Capsule Endoscopy (CCE)
- L33736 Commodes
- L38709 Computed Tomography Cerebral Perfusion Analysis (CTP)
- L34213 Diagnostic and Therapeutic Colonoscopy
- L34315 Electrocardiograms
- L38955 Enteral Nutrition
- L39240 Epidural Steroid Injections for Pain Management
- L33317 External Breast Prostheses
- L33794 External Infusion Pumps
- L39591 External Upper Limb Tremor Stimulator Therapy
- L33737 Eye Prostheses
- L38801 Facet Joint Interventions for Pain Management
- L33738 Facial Prostheses
- L37502 Frequency of Hemodialysis
- L33822 Glucose Monitors
- L36864 GlycoMark® Testing for Glycemic Control
- L33784 Heating Pads and Heat Lamps
- L33785 High Frequency Chest Wall Oscillation Devices
- L33820 Hospital Beds And Accessories
- L38310 Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
- L34314 Immune Globulin Intravenous (IVIg)
- L33824 Immunosuppressive Drugs
- L38657 Implantable Continuous Glucose Monitors (I-CGM)
- L37628 In Vitro Chemosensitivity & Chemoresistance Assays
- L33825 Infrared Heating Pad Systems
- L34218 Injections - Tendon, Ligament, Ganglion Cyst, Tunnel Syndromes and Morton's Neuroma
- L39960 Intervertebral Disc Repair
- L39642 Intraosseous Basivertebral Nerve Ablation
- L33786 Intrapulmonary Percussive Ventilation System
- L33610 Intravenous Immune Globulin
- L33318 Knee Orthoses
- L36678 Lab: Bladder/Urothelial Tumor Markers
- L37066 Lab: Coenzyme Q10 (CoQ10)
- L37616 Lab: Cystatin C Measurement
- L34215 Lab: Flow Cytometry
- L36351 Lab: Special Histochemical Stains and Immunohistochemical Stains
- L36353 Lab: Special Histochemical Stains and Immunohistochemical Stains
- L33787 Lower Limb Prostheses
- L34220 Lumbar MRI
- L37620 MDS FISH
- L37373 MRI and CT Scans of the Head and Neck
- L37729 Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor and Tremor Dominant Parkinson's Disease
- L33788 Manual Wheelchair Bases
- L36846 Measurement of Salivary Hormones
- L33795 Mechanical In-exsufflation Devices
- L38299 Micro-Invasive Glaucoma Surgery (MIGS)
- L39810 Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ)
- L35702 Mohs Micrographic Surgery
- L40197 MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
- L36358 MolDX: Biomarkers in Cardiovascular Risk Assessment
- L38331 MolDX: Blood Product Molecular Antigen Typing
- L36380 MolDX: Breast Cancer Assay: Prosigna®
- L37822 MolDX: Breast Cancer Index® (BCI) Gene Expression Test
- L37070 MolDX: DecisionDx-UM (Uveal Melanoma)
- L37295 MolDX: EndoPredict® Breast Cancer Gene Expression Test
- L37887 MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test
- L39686 MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers
- L40242 MolDX: Genetic Testing for Hereditary Thrombophilia
- L39944 MolDX: Genetic Testing for Heritable Thoracic Aortic Disease
- L36155 MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)
- L36551 MolDX: HLA-DQB1*06:02 Testing for Narcolepsy
- L37897 MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer
- L38972 MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
- L36188 MolDX: MGMT Promoter Methylation Analysis
- L37750 MolDX: Melanoma Risk Stratification Molecular Testing
- L38814 MolDX: Minimal Residual Disease Testing for Cancer
- L39373 MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma
- L39589 MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
- L39467 MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
- L39678 MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy
- L39005 MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
- L35160 MolDX: Molecular Diagnostic Tests (MDT)
- L39001 MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
- L39262 MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia
- L39948 MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis
- L39682 MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules
- L40060 MolDX: Molecular Testing for Solid Organ Allograft Rejection
- L40062 MolDX: Molecular Testing for Solid Organ Allograft Rejection
- L36335 MolDX: NRAS Genetic Testing
- L38123 MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
- L38119 MolDX: Next-Generation Sequencing for Solid Tumors
- L40222 MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer
- L39923 MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
- L36941 MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
- L38335 MolDX: Pharmacogenomics Testing
- L38643 MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
- L38151 MolDX: Pigmented Lesion Assay
- L39230 MolDX: Plasma-Based Genomic Profiling in Solid Tumors
- L38327 MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer
- L38647 MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
- L37299 MolDX: Prometheus® IBD sgi Diagnostic® Policy
- L38339 MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
- L38351 MolDX: Repeat Germline Testing
- L33370 Nebulizers
- L33821 Negative Pressure Wound Therapy Pumps
- L35456 Nerve Blockade for Treatment of Chronic Pain and Neuropathy
- L36524 Nerve Conduction Studies and Electromyography
- L38613 Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
- L33826 Oral Anticancer Drugs
- L33827 Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics)
- L33611 Oral Appliances for Obstructive Sleep Apnea
- L33641 Orthopedic Footwear
- L33796 Osteogenesis Stimulators
- L33828 Ostomy Supplies
- L33797 Oxygen and Oxygen Equipment
- L38953 Parenteral Nutrition
- L33799 Patient Lifts
- L34228 Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF)
- L40265 Peripheral Nerve Injections and Procedures for Chronic Pain
- L34328 Peripheral Nerve Stimulation
- L35163 Plastic Surgery
- L39058 Platelet Rich Plasma Injections for Non-Wound Injections
- L36861 Polysomnography and Other Sleep Studies
- L33718 Positive Airway Pressure (PAP) Devices for the Treatment of Obstructive Sleep Apnea
- L33789 Power Mobility Devices
- L33830 Pressure Reducing Support Surfaces - Group 1
- L33642 Pressure Reducing Support Surfaces - Group 2
- L33692 Pressure Reducing Support Surfaces - Group 3
- L36704 ProMark® Risk Score
- L33793 Refractive Lenses
- L33800 Respiratory Assist Devices
- L34149 Respiratory Care
- L39462 Sacroiliac Joint Injections and Procedures
- L33801 Seat Lift Mechanisms
- L36702 Serum Magnesium
- L33739 Speech Generating Devices (SGD)
- L35136 Spinal Cord Stimulators for Chronic Pain
- L33790 Spinal Orthoses: TLSO and LSO
- L33612 Suction Pumps
- L40176 Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)
- L33831 Surgical Dressings
- L40255 Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices
- L33369 Therapeutic Shoes for Persons with Diabetes
- L34163 Total Hip Arthroplasty
- L36575 Total Knee Arthroplasty
- L33832 Tracheostomy Care Supplies
- L37086 Transcranial Magnetic Stimulation (TMS)
- L34821 Transcutaneous Electrical Joint Stimulation Devices (TEJSD)
- L33802 Transcutaneous Electrical Nerve Stimulators (TENS)
- L38705 Transurethral Waterjet Ablation of the Prostate
- L36538 Treatment of Males with Low Testosterone
- L34209 Treatment of Varicose Veins of the Lower Extremities
- L34211 Trigger Point Injections (TPI)
- L34823 Tumor Treatment Field Therapy (TTFT)
- L36668 Urine Drug Testing
- L33803 Urological Supplies
- L34824 Vacuum Erection Devices (VED)
- L36692 Vitamin D Assay Testing
- L33791 Walkers
- L33792 Wheelchair Options/Accessories
- L33312 Wheelchair Seating
- L38902 Wound and Ulcer Care
How to use this contractor's policies
A Local Coverage Determination applies only to claims processed by the contractor that wrote it, so the first question is which jurisdiction the rendering location falls in; the contracts table above answers that for institutional and professional claims, and durable medical equipment follows the DME MAC region instead. Each LCD states the covered indications, the documentation the record must contain and, through its companion Billing and Coding Article, the ICD-10 codes that support medical necessity and the HCPCS codes the policy edits. When a claim denies with CARC 50 and remark N115, the remark names the LCD; open it from the list above, compare the diagnosis on the claim with the article's covered list, and build the appeal on the documentation requirements rather than on the policy itself. Where this contractor has no LCD for a service and no National Coverage Determination exists, coverage is decided claim by claim under the reasonable-and-necessary standard, which is where prior authorization and pre-service review earn their keep.
Frequently asked questions
Which states does Noridian Healthcare Solutions, LLC cover?
Noridian Healthcare Solutions, LLC holds 30 Medicare contracts (01111 A and B MAC; 01112 A and B MAC; 01182 A and B MAC; 01211 A and B MAC; 01212 A and B MAC; 01311 A and B MAC; 01312 A and B MAC; 01911 A and B MAC; 02101 A and B MAC; 02102 A and B MAC; 02201 A and B MAC; 02202 A and B MAC; 02301 A and B MAC; 02302 A and B MAC; 02401 A and B MAC; 02402 A and B MAC; 03101 A and B MAC; 03102 A and B MAC; 03201 A and B MAC; 03202 A and B MAC; 03301 A and B MAC; 03302 A and B MAC; 03401 A and B MAC; 03402 A and B MAC; 03501 A and B MAC; 03502 A and B MAC; 03601 A and B MAC; 03602 A and B MAC; 16013 DME MAC; 19003 DME MAC) covering AK, AS, AZ, CA, CNMI, CT, DC, DE, GU, HI, IA, ID, KS, MA, MD, ME, MO, MT, ND, NE, NF, NH, NJ, NV, NY, OR, PA, RI, SD, SF, UT, VT, WA, WY.
How many LCDs does Noridian Healthcare Solutions, LLC have?
174 Local Coverage Determinations are active in the current Medicare Coverage Database export for Noridian Healthcare Solutions, LLC. Each LCD applies only in that contractor's jurisdiction, so the same service can be covered differently in a neighbouring state.
What is the difference between an LCD and an NCD?
A National Coverage Determination is set by CMS and binds every contractor. A Local Coverage Determination is written by one Medicare Administrative Contractor for its jurisdiction and cannot conflict with an NCD; where no NCD exists, the LCD is the controlling policy.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-02. Verify against the primary file before billing or contracting decisions.
- Medicare Coverage Database, current LCD exportVersion MCD release 2026-09-24 · effective 2026-09-20 · file lcd.csvSHA-256 2fcc4251b6ddd1eb…
Disclaimer
Contractor jurisdictions and LCD lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify coverage against the current LCD text on cms.gov or the contractor site before billing. Not legal, clinical or billing advice.